SMTL ID : 4ehr.1

Crystal structure of Bcl-Xl complex with 4-(5-butyl-3-(hydroxymethyl)-1-phenyl-1h-pyrazol-4-yl)-3-(3,4-dihydro-2(1h)-isoquinolinylcarbonyl)-n-((2-(trimethylsilyl)ethyl)sulfonyl)benzamide

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.09 Å

Oligo State

monomer

Ligands

1 x 0Q5: 4-[5-butyl-3-(hydroxymethyl)-1-phenyl-1H-pyrazol-4-yl]-3-(3,4-dihydroisoquinolin-2(1H)-ylcarbonyl)-N-{[2-(trimethylsilyl)ethyl]sulfonyl}benzamide(Non-covalent)

0Q5.1: 16 residues within 4Å: Chain A: A.56, E.59, F.60, R.63, Y.64, A.67, F.68, L.71, V.89, E.92, L.93, G.101, R.102, V.104, A.105, F.109 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:F.60, A:F.60, A:Y.64, A:Y.64, A:A.67, A:F.68, A:L.71, A:V.89, A:E.92, A:F.109 Hydrogen bonds: A:R.63, A:Y.64, A:R.102, A:R.102 Water bridges: A:R.95, A:Y.158

1 x IMD: IMIDAZOLE(Non-covalent)

IMD.2: 5 residues within 4Å: Chain A: V.13, L.16, Q.29, V.126, A.130 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Schroeder, G.M. et al., Pyrazole and pyrimidine phenylacylsulfonamides as dual Bcl-2/Bcl-xL antagonists. Bioorg.Med.Chem.Lett. (2012)

Release Date

2012-06-06

Peptides

Bcl-2-like protein 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Bcl-2-like protein 1